135 related articles for article (PubMed ID: 28315254)
1. Live-Cell Imaging of Protease Activity: Assays to Screen Therapeutic Approaches.
Chalasani A; Ji K; Sameni M; Mazumder SH; Xu Y; Moin K; Sloane BF
Methods Mol Biol; 2017; 1574():215-225. PubMed ID: 28315254
[TBL] [Abstract][Full Text] [Related]
2. Pathomimetic cancer avatars for live-cell imaging of protease activity.
Ji K; Heyza J; Cavallo-Medved D; Sloane BF
Biochimie; 2016 Mar; 122():68-76. PubMed ID: 26375517
[TBL] [Abstract][Full Text] [Related]
3. Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer.
Ji K; Sameni M; Osuala K; Moin K; Mattingly RR; Sloane BF
Cancer Metastasis Rev; 2019 Sep; 38(3):445-454. PubMed ID: 31605250
[TBL] [Abstract][Full Text] [Related]
4. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression.
Sameni M; Anbalagan A; Olive MB; Moin K; Mattingly RR; Sloane BF
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371028
[TBL] [Abstract][Full Text] [Related]
5. Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound.
Ramalho SD; Sharma R; White JK; Aggarwal N; Chalasani A; Sameni M; Moin K; Vieira PC; Turro C; Kodanko JJ; Sloane BF
PLoS One; 2015; 10(11):e0142527. PubMed ID: 26562785
[TBL] [Abstract][Full Text] [Related]
6. 3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment.
Moin K; Sameni M; Victor BC; Rothberg JM; Mattingly RR; Sloane BF
Methods Enzymol; 2012; 506():175-94. PubMed ID: 22341225
[TBL] [Abstract][Full Text] [Related]
7. Imaging and quantifying the dynamics of tumor-associated proteolysis.
Sameni M; Cavallo-Medved D; Dosescu J; Jedeszko C; Moin K; Mullins SR; Olive MB; Rudy D; Sloane BF
Clin Exp Metastasis; 2009; 26(4):299-309. PubMed ID: 19082919
[TBL] [Abstract][Full Text] [Related]
8. Live-Cell High Content Screening in Drug Development.
Esner M; Meyenhofer F; Bickle M
Methods Mol Biol; 2018; 1683():149-164. PubMed ID: 29082492
[TBL] [Abstract][Full Text] [Related]
9. Imaging proteolysis by living human breast cancer cells.
Sameni M; Moin K; Sloane BF
Neoplasia; 2000; 2(6):496-504. PubMed ID: 11228542
[TBL] [Abstract][Full Text] [Related]
10. Protein Translocation Assays to Probe Protease Function and Screen for Inhibitors.
Hahlbrock A; Gößwein D; Stauber RH
Methods Mol Biol; 2017; 1574():227-241. PubMed ID: 28315255
[TBL] [Abstract][Full Text] [Related]
11. Cell-Based Assay Design for High-Content Screening of Drug Candidates.
Nierode G; Kwon PS; Dordick JS; Kwon SJ
J Microbiol Biotechnol; 2016 Feb; 26(2):213-25. PubMed ID: 26428732
[TBL] [Abstract][Full Text] [Related]
12. Imaging Proteolytic Activities in Mouse Models of Cancer.
Pal A; Rehemtulla A
Methods Mol Biol; 2018; 1731():247-260. PubMed ID: 29318559
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the autophagy-triggering effects of drugs in cell spheroids with live fluorescence microscopy.
Ansari N; Hardung S; Hötte K; Rakel S; Antonietti P; Kögel D; Stelzer EH; Pampaloni F
Methods Mol Biol; 2014; 1165():19-29. PubMed ID: 24839016
[TBL] [Abstract][Full Text] [Related]
14. High-content screening of natural products reveals novel nuclear export inhibitors.
Cautain B; de Pedro N; Murillo Garzón V; Muñoz de Escalona M; González Menéndez V; Tormo JR; Martin J; El Aouad N; Reyes F; Asensio F; Genilloud O; Vicente F; Link W
J Biomol Screen; 2014 Jan; 19(1):57-65. PubMed ID: 24045581
[TBL] [Abstract][Full Text] [Related]
15. High-Throughput Whole-Plate Imaging of Cells for Multiple Biological Applications.
Sukumar UK; Habte F; Massoud TF; Paulmurugan R
Methods Mol Biol; 2021; 2274():367-384. PubMed ID: 34050486
[TBL] [Abstract][Full Text] [Related]
16. Functional imaging of tumor proteolysis.
Sloane BF; Sameni M; Podgorski I; Cavallo-Medved D; Moin K
Annu Rev Pharmacol Toxicol; 2006; 46():301-15. PubMed ID: 16402907
[TBL] [Abstract][Full Text] [Related]
17. Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.
Hillebrand LE; Bengsch F; Hochrein J; Hülsdünker J; Bender J; Follo M; Busch H; Boerries M; Reinheckel T
Oncotarget; 2016 Sep; 7(36):58244-58260. PubMed ID: 27542270
[TBL] [Abstract][Full Text] [Related]
18. Monitoring protease activity in biological tissues using antibody prodrugs as sensing probes.
Vasiljeva O; Menendez E; Nguyen M; Craik CS; Michael Kavanaugh W
Sci Rep; 2020 Apr; 10(1):5894. PubMed ID: 32246002
[TBL] [Abstract][Full Text] [Related]
19. 3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis.
Booij TH; Price LS; Danen EHJ
SLAS Discov; 2019 Jul; 24(6):615-627. PubMed ID: 30817892
[TBL] [Abstract][Full Text] [Related]
20. Highly multiplexed phenotypic imaging for cell proliferation studies.
Cappella P; Gasparri F
J Biomol Screen; 2014 Jan; 19(1):145-57. PubMed ID: 23896684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]